Cellcast plc Update on the Lexinta fund and trading (7058Y)
December 07 2017 - 6:00AM
UK Regulatory
TIDMCLTV
RNS Number : 7058Y
Cellcast plc
07 December 2017
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014.
07 December 2017
Cellcast plc
("Cellcast" or the "Company")
Update on the Lexinta fund and trading
Lexinta fund update
On the 13th November 2017, the Company issued an announcement
regarding its investment in the Lexinta fund, the carrying value of
which is currently stated in the Company's accounts at
GBP754,358.
Despite continued attempts by the Company, the manager of the
Lexinta fund has refused to engage in meaningful discussions with
the fund's investors regarding the investments within the fund.
The Company is aware that a number of investors in the Lexinta
fund have complained to FINMA, the Swiss financial regulators, and
a large group of investors have filed a criminal complaint against
the fund manager with the Swiss Department of Public Prosecutions.
The Company understands that these filings have now been confirmed
as being received and are being acted upon.
The Company has engaged lawyers in London and Zurich to advise
it in pursuing the appropriate claims against the Lexinta fund,
Lexinta AG (the manager of the fund) and the individual fund
manager, Bismark Badilla. The Company is also seeking to work with
other investors in the Lexinta fund to pursue a complementary
course of action, so as to ensure that the Company does not
duplicate effort and work, and thereby save money, and maximise any
returns. The Company is currently considering the appropriate level
of provision against the carrying value of its investment in the
Lexinta fund.
The Company will issue a further update in due course to confirm
actions taken, the level of any provision and progress
achieved.
Current trading update
On the 13th November 2017 the Company commented on its
profitable trading since its new supplier agreements came into
force in August 2017. This positive trading has continued into the
final months of the year and the Company now expects to reverse its
first 6 months of losses in the second half of the year and show a
small profit for the year as a whole (before any provision for the
carrying value of its investments in the Lexinta fund).
The Company is cautiously optimistic about several of the new
key initiatives it has undertaken in order to save costs and to
generate new income streams going forward. Whilst the issues with
the Lexinta fund are not welcomed the Company has sufficient cash
available to it for its working capital requirements.
For further information:
Cellcast plc 020 3376 9420
Mike Neville - Non-Executive Chairman
Craig Gardiner - Chief Executive
Officer
Emmanuelle Guicharnaud - Finance
Director
Allenby Capital Limited (Nominated
Adviser and Broker) 0203 328 5656
Nick Naylor / James Reeve
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCTRBBTMBAMBMR
(END) Dow Jones Newswires
December 07, 2017 07:00 ET (12:00 GMT)
Cellcast (LSE:CLTV)
Historical Stock Chart
From Apr 2024 to May 2024
Cellcast (LSE:CLTV)
Historical Stock Chart
From May 2023 to May 2024